Circulating AIM Prevents Hepatocellular Carcinoma Through Complement Activation

Cell Reports - United States
doi 10.1016/j.celrep.2014.08.058
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Persistent Activation of Nrf2 Through P62 in Hepatocellular Carcinoma Cells

Journal of Cell Biology
MedicineCell Biology
2011English

Complement C4 Prevents Viral Infection Through Capsid Inactivation

Cell Host and Microbe
ImmunologyMolecular BiologyCancer ResearchVirologyMicrobiologyMicrobiology Parasitology
2019English

Purified Vitexin Compound 1 Induces Apoptosis Through Activation of FOXO3a in Hepatocellular Carcinoma

Oncology Reports
MedicineCancer ResearchOncology
2013English

Β1 Integrin-Mediated Multicellular Resistance in Hepatocellular Carcinoma Through Activation of the FAK/Akt Pathway

Journal of International Medical Research
BiochemistryMedicineCell Biology
2018English

Circulating Cell-Free DNA in Hepatocellular Carcinoma: Current Insights and Outlook

Frontiers in Medicine
Medicine
2018English

Regorafenib Inhibits Tumor Progression Through Suppression of ERK/NF-κB Activation in Hepatocellular Carcinoma Bearing Mice

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2018English

Shp2 SUMOylation Promotes ERK Activation and Hepatocellular Carcinoma Development

Oncotarget
Oncology
2015English

Rpb3 Promotes Hepatocellular Carcinoma Through Its N-Terminus

Oncotarget
Oncology
2014English

Circulating Exosomal Non-Coding RNAs as Prognostic Biomarkers in Human Hepatocellular Carcinoma

International Journal of Cancer
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy